NASDAQ · Health care

COMPASS Pathways plc (CMPS)

It posted a net loss of $266.3M. At September 30, 2026 it held $444M in cash against $51M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 3, 2026.

Watch CMPS in 60 seconds

Price

$9.18

0.00% on the day · November 10, 2026

52-week range $4.88 to $15.87

Market cap

$1.3B

Key facts about COMPASS Pathways plc

Net worth: COMPASS Pathways plc has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of $142.1M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Cash flow: In fiscal 2025 operations used $157.2M of cash.
Latest report: The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 3, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report: COMPASS Pathways plc's next report is expected around March 23, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What COMPASS Pathways plc does

COMPASS Pathways plc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CMPS.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	-$179M	-$287.9M	-$3.08	n/a
2024	n/a	-$178.2M	-$155.1M	-$2.30	-$119.2M
2023	n/a	-$136.9M	-$118.5M	-$2.32	-$97.4M
2022	n/a	-$110.4M	-$91.5M	-$2.16	-$106M
2021	n/a	-$83.2M	-$71.7M	-$1.79	-$68.1M
2020	n/a	-$51.4M	-$60.3M	-$3.55	-$41.5M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around March 23, 2027.

Estimated from its filing rhythm: 52 weeks after its report of March 24, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Latest SEC filings

What COMPASS Pathways plc has filed recently, newest first. Each links to the original document on SEC EDGAR.

November 3, 2026
Quarterly results 8-K
November 3, 2026
Quarterly report 10-Q · period to September 30, 2026Diluted EPS -$0.31 versus -$1.44.
October 28, 2026
Passive stake (5% or more) SCHEDULE 13G
August 5, 2026
Shelf registration to sell securities S-3ASR
August 5, 2026
Quarterly results 8-K
August 5, 2026
Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$1.88 versus -$0.41.
July 7, 2026
Investor disclosure 8-K
May 28, 2026
Shareholder vote results 8-K
May 15, 2026
Passive stake changed SCHEDULE 13G/A
May 13, 2026
Quarterly results 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 10, 2026. Insider transactions on SEC

Insider trades

What the people running COMPASS Pathways plc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)

last 90 days

Sold

last 90 days

Date	Insider	What	Shares	Price	Value	Filing
August 3, 2026	Nath KabirChief Executive Officer, Director	Shares withheld for tax	5,962	$11.25	$67.1K	Form 4
March 26, 2026	Loxam TeriChief Financial Officer	Received as pay	75,000	-	-	Form 4
March 26, 2026	Nath KabirChief Executive Officer, Director	Received as pay	175,000	-	-	Form 4
March 11, 2026	Loxam TeriChief Financial Officer	Shares withheld for tax	1,781	$6.89	$12.3K	Form 4
March 11, 2026	Nath KabirChief Executive Officer, Director	Shares withheld for tax	13,131	$6.89	$90.5K	Form 4
March 2, 2026	Loxam TeriChief Financial Officer	Shares withheld for tax	4,467	$7.02	$31.4K	Form 4
February 2, 2026	Nath KabirChief Executive Officer, Director	Shares withheld for tax	16,181	$6.61	$107K	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CMPS

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Deep Track Capital, LP13G, passive with 2 related filers	9.99%	9,274,589	January 17, 2025
RTW Investments, LP13G, passive with 1 related filers	9.9%	12,971,571	May 15, 2026
ATAI Life Sciences N.V.13D, may seek influence with 1 related filers	6%	5,785,774	October 29, 2025
BIT Capital GmbH13G, passive	5.9%	8,148,280	October 28, 2026

Latest filings below 5%: Vivo Opportunity Fund Holdings, L.P. 3.2% (November 14, 2025); Nantahala Capital Management, LLC 3.57% (November 14, 2025); Chen Yu 3.9% (August 14, 2025); Millennium Management LLC 3% (May 7, 2025); Kenneth Griffin 1.7% (February 14, 2025).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 223 managers reported a position.

Holder	Shares	Value	Change on quarter
Deep Track Capital, LP	12,161,496	$172.1M	0
Rtw Investments, LP	10,700,974	$151.4M	+68,584
BIT Capital GmbH	6,348,797	$89.8M	+2,857,563
Tang Capital Management LLC	5,000,000	$70.8M	+997,800
Two Sigma Investments, LP	4,470,485	$63.3M	+1,886,986
Marshall Wace, Llp	4,328,682	$61.3M	+290,347
ARK Investment Management LLC	3,451,965	$48.8M	+150,915
Point72 Asset Management, L.P.	2,620,878	$37.1M	new
Logos Global Management LP	2,250,000	$31.8M	new
Eagle Health Investments LP	2,060,427	$29.2M	0
Bank of America Corp	2,019,348	$28.6M	+1,987,016
DAFNA Capital Management LLC	2,011,952	$28.5M	-406,930
NEXTBio Capital Management LP	1,775,759	$25.1M	-245,648
Kalehua Capital Management LLC	1,639,384	$23.2M	0
UBS Group AG	1,482,470	$21M	-372,600
Aisling Capital Management LP	1,432,336	$20.3M	0
Renaissance Technologies LLC	1,431,889	$20.3M	+566,535
Candriam S.C.A.	1,274,278	$18M	new
Woodline Partners LP	1,086,004	$15.4M	+910,565
Citadel Advisors LLC	1,004,880	$14.2M	+735,391

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

2 insiders reported holding 513,030 shares in total, about $4.7M at the last price.

Holder	Shares	As of
Nath KabirChief Executive Officer, Director	361,028	August 3, 2026
Loxam TeriChief Financial Officer	152,002	March 26, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CMPS

What does COMPASS Pathways plc do?

COMPASS Pathways plc is a company in the Health care sector, listed on NASDAQ as CMPS. Its shares trade on NASDAQ under the ticker CMPS.

What is COMPASS Pathways plc's net worth?

COMPASS Pathways plc has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of $142.1M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is COMPASS Pathways plc profitable?

No. Over the twelve months to September 30, 2026 it reported a net loss of $266.3M.

When did COMPASS Pathways plc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 3, 2026. It covers the period to September 30, 2026.

When is COMPASS Pathways plc's next earnings report?

COMPASS Pathways plc's next report is expected around March 23, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

OMER

Omeros Corp

CRVS

Corvus Pharmaceuticals, Inc.

Seaport Therapeutics, Inc.

APMD

Apnimed, Inc.

Compare CMPS with

Compare CMPS with any company

Follow CMPS

Get an email when COMPASS Pathways plc files with the SEC: results, executive changes, material agreements and annual reports.

Where the numbers come from

Financial figures are the values COMPASS Pathways plc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.